Cargando…

Endothelial cells from cord blood CD133(+)CD34(+) progenitors share phenotypic, functional and gene expression profile similarities with lymphatics

The existence of endothelial progenitor cells (EPC) with high cell-cycle rate in human umbilical cord blood has been recently shown and represents a challenging strategy for therapeutic neovascularization. To enhance knowledge for future cellular therapy, we compared the phenotypic, functional and g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Van Anh, Fürhapter, Christina, Obexer, Petra, Stössel, Hella, Romani, Nikolaus, Sepp, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822512/ https://www.ncbi.nlm.nih.gov/pubmed/18410526 http://dx.doi.org/10.1111/j.1582-4934.2008.00340.x

Ejemplares similares

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

Mobilization of CD133(+) Progenitor Cells in Patients with Acute Cerebral Infarction
por: Sepp, Dominik, et al.
Publicado: (2014)

Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
por: Bogoslovsky, Tanya, et al.
Publicado: (2011)

Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2023)

Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133(+) and CD34(+) Hematopoietic Stem and Progenitor Cells
por: Bissels, Ute, et al.
Publicado: (2011)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

CD34(+)VEGFR-3(+) progenitor cells have a potential to differentiate towards lymphatic endothelial cells
por: Tan, Yu-zhen, et al.
Publicado: (2014)

The CD133 and CD34 cell types in human umbilical cord blood have the capacity to produce infectious dengue virus particles
por: Vats, Amrita, et al.
Publicado: (2023)

Surface expression of CXCR4 on circulating CD133(+ )progenitor cells is associated with plaque instability in subjects with carotid artery stenosis
por: Sepp, Dominik, et al.
Publicado: (2009)

Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor
por: Weng, Lihong, et al.
Publicado: (2016)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients
por: Patry, Christian, et al.
Publicado: (2018)

Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy
por: Xiao, Andrew Y., et al.
Publicado: (2022)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Isolation of Murine Myeloid Progenitor Populations by CD34/CD150 Surface Markers
por: Olender, Leonid, et al.
Publicado: (2022)

CD34(+)-derived Langerhans cell-like cells are different from epidermal Langerhans cells in their response to thymic stromal lymphopoietin
por: Nguyen, Van Anh, et al.
Publicado: (2011)

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
por: Takahashi, M, et al.
Publicado: (2014)

Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma
por: Ritz, Ulrike, et al.
Publicado: (2014)

Osteoprotegerin Induces CD34(+) Differentiation in Endothelial Progenitor Cells
por: Boisson-Vidal, Catherine, et al.
Publicado: (2018)

Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Migration of dendritic cells into the lymphatics: the Langerhans cell example
por: Romani, N, et al.
Publicado: (2003)

A double blinded, placebo-controlled pilot study to examine reduction of CD34 (+)/CD117 (+)/CD133 (+) lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2017)

CD40 Ligation on Human Cord Blood CD34(+)Hematopoietic Progenitors Induces Their Proliferation and Differentiation into Functional Dendritic Cells
por: Flores-Romo, Leopoldo, et al.
Publicado: (1997)

Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
por: Zhang, Zhe, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Human Pluripotent Stem Cells Differentiated in Fully Defined Medium Generate Hematopoietic CD34(+) and CD34(−) Progenitors with Distinct Characteristics
por: Chicha, Laurie, et al.
Publicado: (2011)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Correction: Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma
Publicado: (2014)

Transient loading of CD34(+) hematopoietic progenitor cells with polystyrene nanoparticles
por: Deville, Sarah, et al.
Publicado: (2017)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

CD34 positive cells as endothelial progenitor cells in biology and medicine
por: Hassanpour, Mehdi, et al.
Publicado: (2023)

Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
por: Murata, Miho, et al.
Publicado: (2012)

Effects of pitavastatin on walking capacity and CD34(+)/133(+) cell number in patients with peripheral artery disease
por: Arao, Kenshiro, et al.
Publicado: (2017)

The Chemokine SDF-1 Is a Chemoattractant for Human CD34(+) Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34(+) Progenitors to Peripheral Blood
por: Aiuti, A., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_q13llhbesd5equ170qa8g1f3sm